Download Zipped Amended WP 9 SB0100.ZIP 17,380 Bytes
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

S.B. 100

             1     

PHARMACIST LICENSING AMENDMENTS

             2     
2002 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Sponsor: Peter C. Knudson

             5      This act modifies the Pharmacy Practices Act. The act amends the definition of practice of
             6      pharmacy to include nutritional S [ assessment, therapy, and ] s counseling. The act includes
             7      violating a patient's right to privacy as unprofessional conduct. The act makes technical
             8      amendments.
             9      This act affects sections of Utah Code Annotated 1953 as follows:
             10      AMENDS:
             11          58-17a-102, as last amended by Chapter 162, Laws of Utah 1999
             12          58-17a-502, as last amended by Chapter 162, Laws of Utah 1999
             13      Be it enacted by the Legislature of the state of Utah:
             14          Section 1. Section 58-17a-102 is amended to read:
             15           58-17a-102. Definitions.
             16          In addition to the definitions in Section 58-1-102 , as used in this chapter:
             17          (1) "Administering" means:
             18          (a) the direct application of a prescription drug or device, whether by injection, inhalation,
             19      ingestion, or by any other means, to the body of a human patient or research subject by another
             20      person; or
             21          (b) the placement by a veterinarian with the owner or caretaker of an animal or group of
             22      animals of a prescription drug for the purpose of injection, inhalation, ingestion, or any other
             23      means directed to the body of the animal by the owner or caretaker in accordance with written
             24      directions of the veterinarian.
             25          (2) "Analytical laboratory":
             26          (a) means a facility in possession of prescription drugs for the purpose of analysis; and
             27          (b) does not include a laboratory possessing prescription drugs used as standards and



Text Box

- 2 -
             28
     controls in performing drug monitoring or drug screening analysis if the prescription drugs are
             29      prediluted in a human or animal body fluid, human or animal body fluid components, organic
             30      solvents, or inorganic buffers at a concentration not exceeding one milligram per milliliter when
             31      labeled or otherwise designated as being for in-vitro diagnostic use.
             32          (3) "Animal euthanasia agency" means an agency performing euthanasia on animals by
             33      the use of prescription drugs.
             34          (4) "Board" means the State Board of Pharmacy created in Section 58-17a-201 .
             35          (5) "Branch pharmacy" means a drug outlet or other facility in a rural or medically
             36      underserved area, used for the storage and dispensing of prescription drugs, which is dependent
             37      upon, stocked by, and supervised by a pharmacist in another licensed pharmacy designated and
             38      approved by the division as the parent pharmacy.
             39          (6) "Compounding":
             40          (a) means the preparation, mixing, assembling, packaging, or labeling of reasonable
             41      quantities of a prescription drug or device by a licensed pharmacist or pharmacy intern upon
             42      receipt of a valid prescription or medication order from a practitioner for an individually identified
             43      patient;
             44          (b) includes preparation, mixing, assembling, packaging, or labeling of reasonable
             45      quantities of a prescription drug for the purpose of, or incidental to research, teaching, or chemical
             46      analysis on the condition the prescription drug is not offered for sale or dispensing;
             47          (c) includes the preparation of a reasonable quantity of a prescription drug by a licensed
             48      pharmacist or pharmacy intern in anticipation of a valid prescription or medication order to be
             49      dispensed or administered to a patient based on routine, regularly observed prescribing patterns
             50      of a practitioner; and
             51          (d) does not include the preparation of prescription drugs by a pharmacist or pharmacy
             52      intern for sale to another pharmacist, drug outlet, or the preparation by a pharmacist or pharmacy
             53      intern of any prescription drug in a dosage form which is regularly and commonly available from
             54      a manufacturer in quantities and strengths prescribed by a practitioner.
             55          (7) "Controlled substance" has the same definition as in Section 58-37-2 .
             56          (8) "Device" means an instrument, apparatus, implement, machine, contrivance, implant,
             57      in-vitro reagent, or other similar or related article, including any component part or accessory,
             58      which is required under federal or state law to be prescribed by a practitioner and dispensed by a



Text Box

- 3 -
             59
     pharmacist or pharmacy intern.
             60          (9) "Dispense" means to prepare and deliver a prescription drug or device or
             61      nonprescription drug or device under a lawful order of a practitioner in a suitable container
             62      appropriately labeled for subsequent administration to or use by a patient, research subject, an
             63      animal, or other individual entitled to receive the prescription drug or device.
             64          (10) "Distribute" means to deliver a drug or device other than by administering or
             65      dispensing.
             66          (11) "Drug" or "drugs" means a prescription drug as defined in this chapter.
             67          (12) "Drug outlet" means any person, other than an individual licensed as a pharmacist,
             68      pharmacy technician, or pharmacy intern, who engages in dispensing, delivering, distributing,
             69      manufacturing, or wholesaling prescription drugs or devices within or into this state.
             70          (13) "Drug product equivalent" means a drug product that is designated the therapeutic
             71      equivalent of another drug product in the Approved Drug Products with Therapeutic Equivalence
             72      Evaluations prepared by the Center for Drug Evaluation and Research of the Federal Food and
             73      Drug Administration.
             74          (14) "Drug sample" means a prescription drug packaged in small quantities consistent with
             75      limited dosage therapy of the particular drug, which is marked "sample," is not intended to be sold,
             76      and is intended to be provided to practitioners for the immediate needs of patients for trial
             77      purposes or to provide the drug to the patient until a prescription can be filled by the patient.
             78          (15) "Extern" means a college of pharmacy student enrolled in a college coordinated
             79      practical experience program in a licensed pharmacy under the supervision of a preceptor, as
             80      defined in Subsection (45), and approved by the college of pharmacy.
             81          (16) "Filling" or "refilling" have same meaning as dispense.
             82          (17) "General supervision" means the supervising pharmacist is in the pharmacy or the
             83      facility in which the pharmacy is located and is available for immediate oral contact with the
             84      supervised pharmacy technician or pharmacy intern.
             85          (18) "Hospital pharmacy" means a drug outlet providing pharmaceutical service to
             86      inpatients of a general acute hospital or specialty hospital licensed by the Department of Health
             87      under Title 26, Chapter 21, Health Care Facility Licensing and Inspection Act.
             88          (19) "Institutional pharmacy":
             89          (a) means a drug outlet providing pharmaceutical service to a defined and exclusive group



Text Box

- 4 -
             90
     of patients who have access to the services of the pharmacy because they are treated by or have an
             91      affiliation with a specific entity including health maintenance organizations and infusion
             92      companies; and
             93          (b) does not include hospital pharmacies, drug outlets engaged in retail sales of
             94      prescription drugs and devices to the general public, or the offices of practitioners.
             95          (20) "Labeling" means the process of preparing and affixing a label to the container of any
             96      drug or device, exclusive of the labeling by a manufacturer, packer, or distributor of a
             97      nonprescription drug or commercially packaged legend drug or device. Any label shall include
             98      all information required by federal and state law or rule.
             99          (21) "Licensee" means any person to whom a license has been granted under this chapter.
             100          (22) "Manufacture":
             101          (a) means the production, preparation, propagation, compounding, conversion, or
             102      processing of a prescription drug or a device, either directly or indirectly by extraction from
             103      substances of natural origin or independently by means of chemical synthesis or by a combination
             104      of extraction and chemical synthesis and includes any packaging or repackaging of a substance or
             105      labeling or relabeling of its container; and
             106          (b) does not include the preparation or compounding of a noncontrolled substance drug
             107      by an individual for that individual's own use or the preparation, compounding, packaging, or
             108      labeling of a drug:
             109          (i) by a pharmacist, pharmacy intern, or practitioner incident to administering or
             110      dispensing of a drug in the course of professional practice; or
             111          (ii) by a practitioner or by that practitioner's authorization under supervision for the
             112      purpose of or incident to research, teaching, or chemical analysis and not for sale.
             113          (23) "Medication profile" or "profile" means a record system maintained as to drugs or
             114      devices prescribed for a pharmacy patient to enable a pharmacist, or pharmacy intern to analyze
             115      for potential harmful or dangerous interactions, or other factors, or other drugs or devices
             116      prescribed for the patient.
             117          (24) "Nonprescription drugs" means medicines or drugs which may be sold without a
             118      prescription and which are prepackaged for use by the consumer and labeled in accordance with
             119      the requirements of the statutes and rules of this state and of the federal government.
             120          (25) "Nuclear pharmacy" means a drug outlet providing radiopharmaceutical service.



Text Box

- 5 -
             121
         (26) "Out-of-state mail service pharmacy" means a drug outlet located outside the state
             122      that:
             123          (a) ships, mails, or delivers by any lawful means a dispensed legend drug to a resident in
             124      this state pursuant to a legally issued prescription;
             125          (b) provides information to a resident of this state on drugs or devices which may include,
             126      but is not limited to, advice relating to therapeutic values, potential hazards, and uses; or
             127          (c) counsels pharmacy patients residing in this state concerning adverse and therapeutic
             128      effects of drugs.
             129          (27) "Person" means an individual, corporation, partnership, association, or any other legal
             130      entity.
             131          (28) "Pharmaceutical administration facility" means a health care facility or agency,
             132      including birthing centers, ambulatory surgical facilities, abortion clinics, home health agencies,
             133      hospices, nursing care facilities, end stage renal disease facilities, and penal institutions in which:
             134          (a) a licensed drug outlet is not located;
             135          (b) prescription drugs are held, stored, or are otherwise under the control of the facility or
             136      agency for administration to patients of that facility or agency;
             137          (c) prescription drugs are dispensed to the facility or agency by a licensed pharmacist or
             138      pharmacy intern with whom the facility has established a prescription drug supervising relationship
             139      under which the pharmacist or pharmacy intern provides counseling to the facility or agency staff
             140      as required, and oversees drug control, accounting, and destruction; and
             141          (d) prescription drugs are professionally administered in accordance with the order of a
             142      practitioner by an employee or agent of the facility or agency.
             143          (29) (a) "Pharmaceutical care" means carrying out the following in collaboration with a
             144      prescribing practitioner, and in accordance with division rule:
             145          (i) designing, implementing, and monitoring a therapeutic drug plan intended to achieve
             146      favorable outcomes related to a specific patient for the purpose of curing or preventing the patient's
             147      disease;
             148          (ii) eliminating or reducing a patient's symptoms; or
             149          (iii) arresting or slowing a disease process.
             150          (b) "Pharmaceutical care" does not include prescribing of drugs without consent of a
             151      prescribing practitioner.



Text Box

- 6 -
             152
         (30) "Pharmaceutical dog trainer" means a person who is employed by or under contract
             153      to a law enforcement agency who uses prescription drugs for the purpose of training dogs in the
             154      detection of prescription drugs.
             155          (31) "Pharmaceutical manufacturer" means a person engaged in the manufacture of
             156      prescription drugs or devices.
             157          (32) "Pharmaceutical researcher" means a person who is engaged in conducting scientific
             158      research regarding drugs and their use in accordance with standard research protocols and
             159      techniques, who maintains competent documentation with respect to the research, and who uses
             160      prescription drugs in the conduct of the research.
             161          (33) "Pharmaceutical teaching organization" means an accredited school of pharmacy
             162      within the state, or a school or program meeting the requirements established in accordance with
             163      Subsection 58-17a-302 (4) providing education for pharmacy technicians within the state.
             164          (34) "Pharmaceutical wholesaler/distributor":
             165          (a) means a drug outlet engaged in the business of wholesale vending or selling of any
             166      prescription drug or device to other than the consumer or user of the prescription drug or device,
             167      which the drug outlet has not produced, manufactured, compounded, or dispensed; and
             168          (b) does not include a drug outlet carrying out the following business activities:
             169          (i) intracompany sales;
             170          (ii) the sale, purchase, or trade of a prescription drug or device, or offer to sell, purchase,
             171      or trade a prescription drug or device between hospitals or other health care facilities that are under
             172      common ownership or control of the management and operation of the facilities;
             173          (iii) the sale, purchase, or trade of a prescription drug or device, or offer to sell, purchase,
             174      or trade a prescription drug or device for emergency medical reasons, or to supply another drug
             175      outlet to alleviate a temporary shortage; or
             176          (iv) the distribution of a prescription drug or device as a sample by representatives of a
             177      manufacturer.
             178          (35) "Pharmacist" means an individual licensed by this state to engage in the practice of
             179      pharmacy.
             180          (36) "Pharmacy" means a facility or location where the practice of pharmacy is carried out.
             181          (37) "Pharmacy intern" means an individual licensed by this state to engage in practice as
             182      a pharmacy intern.



Text Box

- 7 -
             183
         (38) "Pharmacy patient" or "patient" means an individual for whom a practitioner has
             184      prescribed a drug or device which is to be administered to or taken or used by that individual or
             185      an animal.
             186          (39) "Pharmacy technician" means an individual licensed by this state to engage in practice
             187      as a pharmacy technician.
             188          (40) "Physician" means an individual licensed by this state to engage in the practice of
             189      medicine.
             190          (41) "Practice as a pharmacy intern" means engaging in the practice of pharmacy under
             191      the general supervision of a licensed pharmacist approved by the division in collaboration with the
             192      board and in accordance with a scope of practice as defined by division rule made in collaboration
             193      with the board.
             194          (42) "Practice as a pharmacy technician":
             195          (a) means engaging in practice as a pharmacy technician under the general supervision of
             196      a licensed pharmacist and in accordance with a scope of practice as defined by division rule made
             197      in collaboration with the board; and
             198          (b) does not include performing a final review of the prescription and prescribed drug
             199      prepared for dispensing, dispensing of the drug, or counseling a patient with respect to a
             200      prescription drug or nonprescription drug.
             201          (43) "Practice of pharmacy" includes any of the following:
             202          (a) interpreting prescription orders;
             203          (b) compounding, packaging, labeling, dispensing, administering, and the coincident
             204      distribution of prescription drugs and devices, provided that the administration of a prescription
             205      drug or device is:
             206          (i) pursuant to a lawful order of a practitioner when one is required by law; and
             207          (ii) in accordance with written guidelines or protocols:
             208          (A) established by the licensed facility in which the prescription drug or device is to be
             209      administered on an inpatient basis; or
             210          (B) approved by the division, in collaboration with the board and the Physician's Licensing
             211      Board, created in Section 58-67-201 , if the prescription drug or device is to be administered on an
             212      outpatient basis solely by a licensed pharmacist;
             213          (c) participating in drug utilization review;



Text Box

House Committee Amendments 2-27-2002 kh/cjd

- 8 -
Senate Committee Amendments 1-28-2002 rd/cjd
             214
         (d) ensuring proper and safe storage of drugs and devices;
             215          (e) maintaining records of drugs and devices in accordance with state and federal law and
             216      the standards and ethics of the profession;
             217          (f) providing information on drugs or devices, which may include advice relating to
             218      therapeutic values, potential hazards, and uses;
             219          (g) providing drug product equivalents;
             220          (h) supervising pharmacist's supportive personnel, pharmacy interns, and pharmacy
             221      technicians;
             222          (i) providing patient counseling, including h :
             222a          (i) h adverse and therapeutic effects of drugs; h [ [ ] and [ ] ]
             222b          (ii) DRUG INTERACTIONS WITH FOOD, NUTRIENTS, AND SUPPLEMENTS; AND h
             223           h [ (j) providing nutritional ] h S [ assessment, therapy, and ] s h [ counseling ] h S [ ;however, this
             223a      Subsection
             224      (43)(j) does not limit the scope of practice of a naturopathic physician licensed under Chapter 71,
             225      Naturopathic Physician Practice Act, or a dietitian certified under Chapter 49, Dietitia
n]

             226      [ Certification Act ] h [ INCLUDING DRUG INTERACTIONS AND THERAPEUTIC EFFECTS OF DRUGS s ;
             226a      and ] h
             227          [(j)] h [ (k) ] (j) h providing pharmaceutical care.
             228          (44) "Practitioner" means any person licensed by the state to prescribe drugs, medications,
             229      or devices dispensed by prescription only.
             230          (45) "Preceptor" means a licensed pharmacist approved by the division in collaboration
             231      with the board to serve as a teacher, example of professional conduct, and supervisor of interns and
             232      externs in the professional practice of pharmacy.
             233          (46) "Prescription" means an order issued by a licensed practitioner, in the course of that
             234      practitioner's professional practice, for a controlled substance, other prescription drug or device
             235      with the intent the prescription drug or device will be used by a patient or an animal. The order
             236      may be issued by word of mouth, written document, telephone, facsimile transmission, computer,
             237      or other electronic means of communication as defined by division rule.
             238          (47) "Prescription drug or device" or "legend drug or device" means:
             239          (a) a drug or device which, under federal law, is required to be labeled with either of the
             240      following statements or their equivalent:
             241          (i) "CAUTION: Federal law prohibits dispensing without prescription"; or
             242          (ii) "CAUTION: Federal law restricts this drug to use by or on the order of a licensed
             243      veterinarian"; or
             244          (b) a drug or device that is required by any applicable federal or state law or rule to be



Text Box

- 9 -
             245
     dispensed on prescription only or is restricted to use by practitioners only.
             246          (48) "Prescription drug or device order" means a lawful written or oral order of a
             247      practitioner for a prescription drug or device for use in humans or animals.
             248          (49) "Retail pharmacy" means a drug outlet dispensing prescription drugs and devices to
             249      the general public.
             250          (50) "Supportive personnel" means unlicensed individuals who:
             251          (a) may assist a pharmacist, pharmacy intern, or pharmacy technician in nonjudgmental
             252      duties not included in the definition of the practice of pharmacy, and as those duties may be further
             253      defined by division rule made in collaboration with the board; and
             254          (b) are supervised by a pharmacist in accordance with rules made by the division in
             255      collaboration with the board.
             256          (51) "Unlawful conduct" is as defined in Sections 58-1-501 and 58-17a-501 .
             257          (52) "Unprofessional conduct" is as defined in Sections 58-1-501 and 58-17a-502 , and as
             258      may be further defined by rule.
             259          (53) "Veterinary pharmaceutical outlet" means a drug outlet dispensing veterinary
             260      prescription drugs.
             261          Section 2. Section 58-17a-502 is amended to read:
             262           58-17a-502. Unprofessional conduct.
             263          "Unprofessional conduct" includes:
             264          (1) willfully deceiving or attempting to deceive the division, the board, or their agents as
             265      to any relevant matter regarding compliance under this chapter;
             266          (2) (a) paying rebates to practitioners or any other health care providers, or entering into
             267      any agreement with a medical practitioner or any other person for the payment or acceptance of
             268      compensation or its economic equivalent for recommending of the professional services of either
             269      party, except as allowed under Subsection (2)(b); and
             270          (b) price discounts conditional upon volume purchases are not prohibited under Subsection
             271      (2)(a);
             272          (3) misbranding or adulteration of any drug or device or the sale, distribution, or
             273      dispensing of any misbranded or adulterated drug or device;
             274          (4) engaging in the sale or purchase of drugs or devices that are samples or packages
             275      bearing the inscription "sample" or "not for resale" or similar words or phrases;



Text Box

- 10 -
Senate Committee Amendments 1-28-2002 rd/cjd
             276
         (5) accepting back and redistributing of any unused drug, or a part of it, after it has left the
             277      premises of any pharmacy, unless the drug is in the original sealed unit dose package or
             278      manufacturer's sealed container;
             279          (6) being employed as a pharmacist, pharmacy intern, or pharmacy technician, or sharing
             280      or receiving compensation in any form arising out of an act incidental to professional activities in
             281      the course of which any person requires him to engage in any aspects of the practice of pharmacy
             282      in violation of this chapter;
             283          (7) violation of Federal Title II, P.L. 91, Controlled Substances Act, or Title 58, Chapter
             284      37, Utah Controlled Substances Act, or rules and regulations adopted under either of them;
             285          (8) requiring or permitting pharmacy interns or technicians to engage in activities outside
             286      the scope of practice for their respective license classifications as defined in this chapter and
             287      division rules made in collaboration with the board, or beyond an individual's scope of training and
             288      ability; [and]
             289          (9) administering without:
             290          (a) appropriate training as defined by rule;
             291          (b) written guidelines or protocols of a practitioner or in conflict with such guidelines or
             292      protocols; or
             293          (c) a lawful order, when one is required by law[.]; and
             294          (10) S [ violating a patient's right to privacy regarding the patient's person, condition,
             295      diagnosis, or other confidential information to any person who does not have:
             296          (a) a legal right to the information concerning the patient; or
             297          (b) a professional need to know the information concerning the patient based on generally
             298      recognized professional or ethical standards that authorize or require disclosure.
] DISCLOSING

             298a      CONFIDENTIAL PATIENT INFORMATION IN VIOLATION OF THE PROVISIONS OF THE HEALTH
             298b      INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 OR OTHER APPLICABLE LAW. s





Legislative Review Note
    as of 12-19-01 1:10 PM


A limited legal review of this legislation raises no obvious constitutional or statutory concerns.

Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]